Mass chemotherapy options to control lymphatic filariasis: a systematic review (Q36209914)

12 August 2017

1 reference

title

Mass chemotherapy options to control lymphatic filariasis: a systematic review (English)

1 reference

12 August 2017

0 references

1 reference

1 reference

3

James W Kazura

1 reference

12 August 2017

Daniel J Tisch

1

1 reference

PubMed ID

16048720

12 August 2017

Edwin Michael

series ordinal

2

1 reference

12 August 2017

1 August 2005

1 reference

Lancet Infectious Diseases

12 August 2017

1 reference

12 August 2017

5

1 reference

12 August 2017

514-523

1 reference

12 August 2017

8

1 reference

Re-assessing the global prevalence and distribution of lymphatic filariasis

12 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Social and economic factors and the control of lymphatic filariasis: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

The economic burden of lymphatic filariasis in northern Ghana

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Lymphatic filariasis: economic aspects of the disease and programmes for its elimination

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

The global programme to eliminate lymphatic filariasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Randomised placebo-controlled comparison of ivermectin and albendazole alone and in combination for Wuchereria bancrofti microfilaraemia in Haitian children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Ivermectin plus diethylcarbamazine: an additive effect on early microfilarial clearance.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Double-blind controlled trial of a single dose of the combination ivermectin 400 μg/kg plus diethylcarbamazine 6 mg/kg for the treatment of bancroftian filariasis: results at six months

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Reduction of Wuchereria bancrofti adult worm circulating antigen after annual treatments of diethylcarbamazine combined with ivermectin in French Polynesia.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Efficacy of albendazole and its combinations with ivermectin or diethylcarbamazine (DEC) in the treatment of Trichuris trichiura infections in Sri Lanka.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Current status and future prospects of the Global Lymphatic Filariasis Programme

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Global mapping of lymphatic filariasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

EPIFIL: the development of an age-structured model for describing the transmission dynamics and control of lymphatic filariasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Prospects for elimination of bancroftian filariasis by mass drug treatment in Pondicherry, India: a simulation study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Ivermectin: effectiveness in lymphatic filariasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

An analysis of the safety of the single dose, two drug regimens used in programmes to eliminate lymphatic filariasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Treatment strategies underpinning the global programme to eliminate lymphatic filariasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Randomized, controlled trials, observational studies, and the hierarchy of research designs

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Comparative efficacy of three different diethylcarbamazine regimens in lymphatic filariasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Effect of two successive annual treatments with single doses of ivermectin on microfilaraemia due to Wuchereria bancrofti var. pacifica.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Dose-ranging study of ivermectin in treatment of filariasis due to Wuchereria bancrofti.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Tolerance of diethylcarbamazine by microfilaraemic and amicrofilaraemic individuals in an endemic area of Bancroftian filariasis, Recife, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Treatment of bancroftian filariasis in Recife, Brazil: a two-year comparative study of the efficacy of single treatments with ivermectin or diethylcarbamazine.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Direct assessment in vivo of the efficacy of combined single-dose ivermectin and diethylcarbamazine against adult Wuchereria bancrofti.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Single-dose treatment of wuchereria bancrofti infections with ivermectin and albendazole alone or in combination: Evaluation of the potential for control at 12 months after treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Clearance of Wuchereria bancrofti antigen after treatment with diethylcarbamazine or ivermectin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Diethylcarbamazine treatment of bancroftian and malayan filariasis with emphasis on side effects

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Prolonged clearance of microfilaraemia in patients with bancroftian filariasis after multiple high doses of ivermectin or diethylcarbamazine.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Long-term efficacy of single-dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Side reactions following ivermectin therapy in high density bancroftian microfilaraemics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Comparison of single-dose diethylcarbamazine and ivermectin for treatment of bancroftian filariasis in Papua New Guinea

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Ivermectin for the treatment of Wuchereria bancrofti filariasis. Efficacy and adverse reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Treatment of co-infection with bancroftian filariasis and onchocerciasis: a safety and efficacy study of albendazole with ivermectin compared to treatment of single infection with bancroftian filariasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

A controlled trial of ivermectin and diethylcarbamazine in lymphatic filariasis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Tolerability and efficacy of single dose albendazole, diethylcarbamazine citrate (DEC) or co-administration of albendazole with DEC in the clearance of Wuchereria bancrofti in asymptomatic microfilaraemic volunteers in Pondicherry, South India: a ho

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Comparison of high dose ivermectin and diethylcarbamazine for activity against bancroftian filariasis in Haiti.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Long-term suppression of microfilaraemia following ivermectin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

A placebo-controlled double-blind trial for the treatment of Bancroftian filariasis with ivermectin or diethylcarbamazine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Bancroftian filariasis: long-term effect of the DEC provocative day test on microfilaraemia

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

The effect of single dose ivermectin alone or in combination with albendazole on Wuchereria bancrofti infection in primary school children in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Tolerability and efficacy of single-dose diethyl carbamazine (DEC) or ivermectin in the clearance of Wuchereria bancrofti microfilaraemia in Pondicherry, south India

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Assessment of combined ivermectin and albendazole for treatment of intestinal helminth and Wuchereria bancrofti infections in Haitian schoolchildren.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Mass treatment to eliminate filariasis in Papua New Guinea

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Placebo-controlled community trial of four cycles of single-dose diethylcarbamazine or ivermectin against Wuchereria bancrofti infection and transmission in India

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

A randomized double-blind placebo-controlled field trial of ivermectin and albendazole alone and in combination for the treatment of lymphatic filariasis in Ghana.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Mass DEC chemotherapy for control of bancroftian filariasis: comparative efficacy of four strategies two years after start of treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Mass diethylcarbamazine chemotherapy for control of bancroftian filariasis: comparative efficacy of standard treatment and two semi-annual single-dose treatments

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Mass diethylcarbamazine chemotherapy for control of bancroftian filariasis through community participation: comparative efficacy of a low monthly dose and medicated salt.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Impact of two annual single-dose mass drug administrations with diethylcarbamazine alone or in combination with albendazole on Wuchereria bancrofti microfilaraemia and antigenaemia in south India

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Annual single-dose diethylcarbamazine plus ivermectin for control of bancroftian filariasis: comparative efficacy with and without vector control

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Selective diethylcarbamazine chemotherapy for control of Bancroftian filariasis in two communities of Tanzania: compared efficacy of a standard dose treatment and two semi-annual single dose treatments.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Direct assessment of the adulticidal efficacy of a single dose of ivermectin in bancroftian filariasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Ivermectin and albendazole alone and in combination for the treatment of lymphatic filariasis in Ghana: Follow-up after re-treatment with the combination

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Og4C3 circulating antigen: a marker of infection and adult worm burden in Wuchereria bancrofti filariasis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

Changes in circulating parasite antigen levels after treatment of bancroftian filariasis with diethylcarbamazine and ivermectin.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2970192-4

7 January 2021

10.1016/S1473-3099(05)70192-4

Identifiers

DOI

1 reference

12 August 2017

1 reference

PubMed ID

16048720